Found 6 matching trials
A Study of Monosialic Gangliosides to Prevent Albumin-bound Paclitaxel Neurotoxicity
PHASE2Taxane-induced peripheral neuropathy (TIPN) caused by paclitaxel is a dose-...
Location
Henan Cancer Hospital
GM1 Prophylaxis for Post-chemotherapy Cognitive Impairment in Patients With Early Operable Breast Cancer
PHASE3The purpose of this study is to evaluate the prophylactic effects of Gangli...
Location
Sun Yat-sen University Cancer Center
Finding an Effective Dose of GM1 to Reduce or Prevent Neuropathy (Numbness or Weakness) Due to Treatment With Paclitaxel (Phase II)
PHASE2This phase II trial tests the safety, side effects, and best dose of monosi...
Location
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
GM1 in the Treatment of Neurotoxicity Induced by Albumin-bound Paclitaxel
PHASE2Taxane-induced peripheral neuropathy (TIPN) caused by albumin-bound paclita...
Location
Henan Cancer Hospital
GM1 Prophylaxis for WBRT Related Cognitive Dysfunction
PHASE3To evaluate the efficacy and safety of GM1 for preventing cognitive impairm...
Location
Sun Yat-sen University Cancer Center
Effect of GM1 in Prevention of Taxanes Induced Neurotoxicity in Operable Breast Cancer
PHASE3Background: Taxane plays a key role in the treatment of breast cancer and t...
Location
Sun Yat-sen University Cancer Center